var data={"title":"Collagen hemostat: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Collagen hemostat: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6580?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196383\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Actifoam Collagen Sponge;</li>\n      <li>Avitene;</li>\n      <li>Avitene Flour;</li>\n      <li>Endo Avitene;</li>\n      <li>Syringe Avitene;</li>\n      <li>Ultrafoam Sponge 2x6.25x7CM;</li>\n      <li>Ultrafoam Sponge 8x12.5x1CM;</li>\n      <li>Ultrafoam Sponge 8x12.5x3CM;</li>\n      <li>Ultrafoam Sponge 8x25x1CM;</li>\n      <li>Ultrafoam Sponge 8x6.25x1CM</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46313697\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Avitene</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196390\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Hemostatic Agent</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196384\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Hemostasis: </b>Topical: Apply dry directly to source of bleeding; remove excess material after ~5 to 10 minutes. If breakthrough bleeding occurs in areas of thin application, additional product may be applied depending on the severity of bleeding (in capillary bleeding, 1 g will usually be sufficient for a 50 cm<sup>2</sup> area; thicker coverage will be required for more brisk bleeding).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196385\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45748856\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45748857\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196373\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Miscellaneous, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Actifoam Collagen Sponge:  (10 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Endo Avitene:  (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Syringe Avitene:  (1 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ultrafoam Sponge 2x6.25x7CM: 2 cm x 6.25 cm x 7 cm (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ultrafoam Sponge 8x12.5x1CM: 8 cm x 12.5 cm x 1 cm (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ultrafoam Sponge 8x12.5x3CM: 8 cm x 12.5 cm x 3 cm (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ultrafoam Sponge 8x25x1CM: 8 cm x 25 cm x 1 cm (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ultrafoam Sponge 8x6.25x1CM: 8 cm x 6.25 cm x 1 cm (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Pad, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Avitene:  (1 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Powder, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Avitene Flour:  (6 ea, 1 g, 5 g)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196361\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45748858\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">For topical use only in in surgical procedures; not for injection, intraocular, or intravascular use. MCH will adhere to wet gloves, instruments, or tissue surfaces; use dry, smooth forceps or a pre-loaded applicator device to apply. Surfaces to be treated should be compressed with dry sponges immediately prior to application. Administer dry (avoiding spillage on nonbleeding surfaces) and then apply pressure over the application site with a dry sponge until hemostasis results (1 minute may suffice for capillary bleeding, but &gt;3 to 5 minutes may be required for brisk bleeding or high pressure leaks in major artery suture holes). For control of oozing from cancellous bone, firmly pack into the spongy bone surface. Avoid packing tightly in cavities, especially within the bony enclosure of the CNS or within other relatively rigid cavities where swelling may interfere with normal function or possibly cause necrosis. After ~5 to10 minutes, remove excess material with blunt forceps and facilitate by wetting with sterile NS and irrigation.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196374\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Hemostasis:</b> Adjunct to hemostasis in surgical procedures when control of bleeding by ligature or conventional procedures is ineffective or impractical.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196395\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Avitene may be confused with Ativan</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Other safety concerns:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Over 100 reports of paralysis or other neural deficits have been received by the FDA, attributable to collagen hemostat-associated neuronal impingement; see Warnings/Precautions</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196368\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Miscellaneous: Adhesion formation, allergic reaction, edema, foreign body reaction, hematoma, inflammation, potentiation of infection </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Postmarketing and/or case reports: Numbness, pain, paralysis, subgaleal seroma; alveolalgia and transient laryngospasm with dental use</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196377\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Closure of skin incisions; application to bone surfaces to which prosthetic materials are attached with methylmethacrylate adhesives.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196365\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Pain/numbness/paralysis: Pain, numbness, or paralysis have been reported if used near a bony or neural space and left inside patient; use minimum amount necessary to achieve hemostasis (FDA, 2004).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Dosage forms specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Sponge: Do not use in instances of pumping arterial hemorrhage, where blood or other fluids have pooled, or where the point of hemorrhage is submerged as it may mask an underlying source of bleeding, resulting in hematoma.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Appropriate use: Not for injection, intraocular, or intravascular use. Do not use as a surface dressing except for immediate control of bleeding; use minimum amount necessary to achieve hemostasis. Avoid spillage on nonbleeding surfaces particularly in abdominal or thoracic viscera. Remove as much of agent as possible after hemostasis is achieved. Do not use in conjunction with autologous blood salvage circuits because fragments of MCH may pass through filters of blood scavenging systems; avoid reintroduction of blood from operative sites treated with MCH. Not intended to treat systemic coagulation disorders. Do not reuse, reprocess, resterilize, or repackage because doing so may lead to device failure or create a risk of contamination of the device and/or cause patient infection or cross infection.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Bovine origin: Contains bovine serum protein; increases in anti-BSA titer have been observed. Use is not recommended in patients sensitive to bovine derived collagen.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Infection: Use in contaminated wounds may enhance infection; do not leave MCH in a contaminated or infected space.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299089\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196369\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=8507&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196364\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Collagen hemostat is an absorbable topical hemostatic agent prepared from purified bovine corium collagen and shredded into fibrils. Physically, microfibrillar collagen hemostat yields a large surface area. Chemically, it is collagen with hydrochloric acid noncovalently bound to some of the available amino groups in the collagen molecules. When in contact with a bleeding surface, collagen hemostat attracts platelets which adhere to its fibrils and undergo the release phenomenon. This triggers aggregation of the platelets into thrombi in the interstices of the fibrous mass, initiating the formation of a physiologic platelet plug.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F196376\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Onset of hemostasis: 2 to 5 minutes</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Avitene (microfibrillar collagen hemostat) [prescribing information]. Warwick, RI: Davol; 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Avitene Ultrafoam (microfibrillar collagen hemostat) [prescribing information]. Warwick, RI: Davol; Received September 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    FDA Public Health Notification: Paralysis from Absorbable Hemostatic Agent. 2004. Available at <a href=\"http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062146.htm\" target=\"_blank\">http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062146.htm</a>.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 8507 Version 51.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F196383\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F46313697\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F196390\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F196384\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F196385\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F45748856\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F45748857\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F196373\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F196361\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F45748858\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F196374\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F196395\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F196368\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F196377\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F196365\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299089\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F196369\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F196364\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F196376\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/8507|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div>","javascript":null}